Latest News and Press Releases

DUBLIN, Ireland and FORT WASHINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of...

Data readouts from multiple clinical trials expected during the next 6 to 12 months Strong cash position of $190.3 million as of December 31, 2021 GAITHERSBURG, Md., March ...

- Dermatologist with over twenty years of experience in senior biopharma roles in the US and Europe, including positions at Almirall, Allergan and Novartis- Strengthens leadership team as eblasakimab...

Pune, March 15, 2022 (GLOBE NEWSWIRE) -- According to the new report published by The Brainy Insights, the global veterinary oncology market is expected to grow from USD 186.96 million in 2020 to...

- Wednesday, March 16, 2022 at 1:30 pm – 2 pm EST - New York, NY and Tel Aviv, ISRAEL, March 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...

Selbyville, Delaware, March 15, 2022 (GLOBE NEWSWIRE) -- U.S. clinical nutrition market value is projected to cross USD 19.7 billion by 2028, according to a new research report by Global Market...

SASKATOON, Saskatchewan, March 15, 2022 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) is pleased to report that it has received positive metallurgical...

VANCOUVER, British Columbia, March 15, 2022 (GLOBE NEWSWIRE) -- Candente Copper Corp. (TSX:DNT, BVL:DNT, US:CDOUF) ("Candente Copper” or “the Company") is pleased to announce that it filed on March...

All MDS-UPDRS Part I, II, III, IV sub-scores improved, including substantial majority of individual items between 71% and 92% SIGMAR1 mRNA expression significantly increased in ANAVEX®2-73-treated...

PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced it has reached a binding...